ConferenceJCO Oncology Practice · September 1, 2024
PURPOSEUnanticipated health care resource utilization, in the form of either emergency department utilization (EDU) or hospital admission (HA), may be an indicator of lower-quality cancer care. The objective of this study was to develop a predictive model ...
Full textCite
ConferenceJournal of Clinical Oncology · January 1, 2024
Background: As the number of young women with early-stage endometrial cancer is increasing, there is growing interest in use of progesterone-based therapy to allow fertility preservation. To date, there is a paucity of data on the safety and long-term outc ...
Full textCite
ConferenceAjog Global Reports · November 1, 2022
BACKGROUND: Telemedicine uses technology to deliver medical care remotely and has been shown to provide similar patient satisfaction and care outcomes compared with in-person visits. OBJECTIVE: This study aimed to assess the gynecologic oncology patient te ...
Full textCite
ConferenceJournal of Clinical Oncology · May 20, 2019
5558 Background: Maintenance therapy with PARP inhibitors has become prevalent in treating ovarian cancer. However, the preferences of women with ovarian cancer regarding the risks, side effects and benefits afforded by maintenan ...
Full textCite
ConferenceJournal of Clinical Oncology · May 20, 2019
1536 Background: Limited information exists regarding appropriate risk-reduction strategies for women with moderate and low penetrance ovarian cancer (OVCA) susceptibility mutations. We sought to assess current practice patterns ...
Full textCite
ConferenceInt J Radiat Oncol Biol Phys · May 1, 2018
PURPOSE: To compare insurance status in cancer patients receiving radiation before and after Medicaid expansion under the Patient Protection and Affordable Care Act (ACA), in both expanded and non-expanded states. METHODS AND MATERIALS: Newly diagnosed can ...
Full textLink to itemCite
ConferenceJournal of Clinical Oncology · May 20, 2017
5549 Background: The value of shared decision-making in ovarian cancer is relatively unexplored. The goal of this study was to test a new decision aid, Patient Centered Outcome Aid (PCOA), that facilitates shared decision-making ...
Full textCite
ConferenceJournal of Clinical Oncology · May 20, 2017
5544 Background: The ASCO value framework allows assessment of novel cancer therapies based on NHB. We assessed novel biologic therapies in the management of PSROC. Methods: ASCO’s revised value framework NHBs were constructed fo ...
Full textCite
ConferenceJournal of Clinical Oncology · May 20, 2017
6608 Background: UKCTOCS is the largest randomized controlled trial to evaluate screening’s impact on ovarian cancer mortality, assigning women to multimodal screening (MMS) with serum CA125 interpreted with a risk algorithm; ann ...
Full textCite
ConferenceJournal of Clinical Oncology · May 20, 2017
5571 Background: Understanding the immune checkpoint marker repertoire can facilitate development of therapeutic strategies to improve efficacy of immune-based therapies. We used a novel high-dimensional flow cytometry panel to d ...
Full textCite
ConferenceJ Minim Invasive Gynecol · February 2015
STUDY OBJECTIVE: To evaluate if the use of Valleylab mode ("V mode") (Covidien, Mansfield, MA) electrothermal energy for colpotomy during total laparoscopic hysterectomy (LH) results in a smaller margin of thermal injury to the upper vagina compared with t ...
Full textLink to itemCite
